Products

OncoStudio (OS-01)
OncoSoft. Co.
Oncology AI
OncoStudio by OncoSoft. Co. is an AI-powered auto-contouring software for radiation oncology that transforms hours of manual organ segmentation into minutes with clinical-grade precision, streamlining treatment planning workflows.

See all 1 product →

About OncoSoft.

OncoSoft is a pioneering medical AI company specializing in advanced software solutions for radiation oncology. Their core products, such as OncoStudio, leverage artificial intelligence to automate critical tasks in radiation therapy, including precise segmentation of normal organs and tumor sites, and organ contour generation. This automation aims to significantly enhance treatment accuracy and efficiency for physicians by minimizing radiation exposure to healthy tissues, thereby reducing side effects and improving patient safety. The software generates consistent, expert-level accurate contours and is compatible with various imaging modalities like CT, MR, and cone-beam CT.

Beyond automated contouring, OncoSoft also offers OncoFlow for integrated workflow management across the entire radiation therapy process. The company is actively developing next-generation AI solutions, including OncoRPT (Radiopharmaceutical Therapy) and OncoPlan (Particle Therapy), to provide a comprehensive platform for cancer diagnosis, treatment planning, and management. OncoSoft’s solutions are currently implemented in over 100 hospitals globally, including the Mayo Clinic, and are designed for seamless integration with existing commercial hardware and software, adhering to international standards such as DICOM.

Focus Areas

AI-based radiation therapy auto-contouring workflow management treatment planning radiopharmaceutical therapy medical image analysis oncology informatics

Business Intelligence

Key InvestorsBNH Investment, HB Investment, Devsisters Ventures, BonAngels Venture Partners, LB Investment
PartnershipsMayo Clinic (USA), AstraZeneca Korea, Yonsei University Health System, Elekta, Terapet SA, Gachon University Gil Medical Center, Japan M3, Weknew, QST (Japan), Amazon Web Services (AWS), Anzai Medical (Japan), University of Chicago Medical Center, VisionRT
TechnologyCloud-native (planned for OncoStudio in 2026), Qt framework, C++, Axivion, Squish, Coco, real-time 3D medical imaging, DICOM, HL7 FHIR, multimodal AI models (including Large Language Models for tumor contouring)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

AI-based Radiation Therapy
OncoSoft develops advanced AI solutions to enhance the precision and efficiency of radiation therapy. Their multimodal AI models, incorporating Large Language Models (LLMs), integrate language-based clinical information with imaging data to create highly accurate and personalized treatment plans.
Auto-Contouring
Their flagship product, OncoStudio, offers revolutionary AI-powered auto-contouring software that transforms hours of manual organ segmentation into minutes with clinical-grade precision. It accurately delineates both organs at risk (OARs) and tumor volumes (CTVs), having processed over 10 million contours for 213,000 patients.
Workflow Management
OncoFlow is OncoSoft's comprehensive workflow management solution designed to integrate the entire radiotherapy workflow into one seamless platform. It automates data flow, reduces manual tasks by up to 75%, eliminates errors, and streamlines every treatment step from initial imaging to follow-up.
Treatment Planning
OncoSoft is actively developing OncoPlan, an AI-guided dosimetry solution aimed at optimizing particle therapy treatments. This will maximize tumor control while minimizing damage to surrounding healthy organs.
Radiopharmaceutical Therapy
The company is developing OncoRPT, a solution to transform radiopharmaceutical therapy (RPT) practice. It will offer personalized dosimetry and integrated patient monitoring to improve treatment precision and safeguard healthy tissues.
Medical Image Analysis
OncoSoft specializes in AI-based image analysis software for radiation oncology, enabling efficient real-time visualization and processing of high-resolution 3D medical images. Their solutions support advanced segmentation and detection for precise treatment planning.
Oncology Informatics
Their platforms streamline workflows for data-driven radiation oncology, providing clinical decision support during treatment selection, results review, and prescribing. They also offer robust data management and analytical reporting capabilities for research and quality improvement.
Physician Tip

OncoSoft's solutions are designed to significantly enhance clinical practice. Physicians can leverage OncoStudio's AI auto-contouring to drastically reduce the time spent on manual segmentation, freeing up valuable time for more complex case review and direct patient interaction. The integration of Large Language Models (LLMs) allows for treatment plans that consider comprehensive clinical context, leading to more precise and personalized patient care. Utilize OncoFlow to automate routine administrative tasks and streamline the entire radiotherapy workflow, minimizing errors and improving inter-departmental coordination. The platform's robust data management and analytical reporting features can be invaluable for clinical research, decision support, and continuous quality improvement initiatives. Furthermore, OncoSoft actively seeks and incorporates physician feedback for product evolution, so engaging with their support team for customized features can tailor the software to specific departmental needs.

OncoSoft's solutions, including OncoStudio and OncoFlow, are built for vendor-neutral integration. They adhere to global standards such as DICOM and HL7 FHIR, ensuring seamless compatibility and interoperability with existing hospital systems, Treatment Planning Systems (TPS), Record & Verify (R&V) systems, Oncology Information Systems (OIS), and diverse radiation therapy equipment from various manufacturers. This eliminates vendor lock-in and facilitates a unified workflow ecosystem.

Products by OncoSoft.

1 product in the directory

OncoStudio (OS-01)
OncoSoft. Co.
Oncology AI
OncoStudio by OncoSoft. Co. is an AI-powered auto-contouring software for radiation oncology that transforms hours of manual organ segmentation into minutes with clinical-grade precision, streamlining treatment planning workflows.

What the Web Says

OncoSoft generally receives positive to mixed reviews, particularly for its specialized oncology EHR and practice management solutions. Users appreciate its tailored features for cancer care, though some report challenges with usability, customer support responsiveness, and integration with other systems. Employer reviews suggest a supportive work environment but with potential for high workload.

Overall: Mixed

Strengths

  • Specialized features for oncology practices (EHR, treatment plans, billing)
  • Improves efficiency in cancer care workflows
  • Dedicated to oncology, offering relevant functionalities
  • Supportive work culture (employer reviews)
  • Comprehensive practice management capabilities
  • Good for managing complex oncology patient data

Limitations

  • Steep learning curve and complex interface for some users
  • Customer support can be slow or inconsistent
  • Integration challenges with third-party systems or labs
  • Occasional bugs or glitches reported
  • Reporting features could be more robust or user-friendly
  • High workload reported by some employees

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Today

Last updated: 2026-07-19

Videos

News, demos, and interviews about OncoSoft..

Loading videos...

Videos load interactively. If none appear, search YouTube for OncoSoft. →

View all on YouTube

Press & Coverage

Oncosoft (via unknown news outlet)
'Radiation therapy AI' company Oncosoft raises $8.03 million Series B funding
Oncosoft announced the finalization of an $8.03 million Series B investment round, led by existing investors BNH Investment, HB Investment, and DevSisters Ventures, with new investors Bon Angels Venture Partners and LB Investment. The funding will be used to accelerate the development of next-generation healthcare AI solutions and expand into the global market.
2024-09
Money Today
Oncosoft Obtains Animal Medical Device Approval for 'OncoVET' for Veterinary Radiation Therapy
Oncosoft's veterinary radiation therapy software, 'OncoVET,' received a Class 2 animal medical device license from the Animal and Plant Quarantine Agency. This solution, based on OncoStudio, optimizes precision image registration and automatic structure segmentation for veterinary anatomical structures, aiming to increase efficiency and reduce waiting times for companion animal cancer treatment.
2025-04
MEDIGATE NEWS
Oncosoft AI Radiotherapy Solution Obtains US FDA 510(k) Clearance
Oncosoft's AI-based automatic contouring solution 'OncoStudio' obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA), officially recognizing its safety and effectiveness in the U.S. market. This follows its approval from the Korean Ministry of Food and Drug Safety (MFDS) in 2022 and adoption by 18 hospitals.
2025-03
Money Today
Oncosoft Selected as '2025 Best AI Radiotherapy Solution in Asia-Pacific'
Oncosoft was selected as the '2025 Best AI Radiotherapy Solution in Asia-Pacific' by 'MedTech Outlook APAC,' a magazine for medical professionals in the region. This award recognizes Oncosoft's technological prowess, with its core products OncoStudio and OncoFlow implemented in over 100 hospitals worldwide.
2025-11
MEDIGATE NEWS
Oncosoft develops radiation cancer treatment technology with LLM for greater accuracy
Oncosoft announced the development of an AI-based tumor contouring technology that increases the accuracy of radiation therapy by 2.36 times, in collaboration with researchers from Yonsei Cancer Hospital and Massachusetts General Hospital. This multimodal AI model, incorporating large language models (LLM), was published in Nature Communications.
2024-11
NewsWire
Qt Group Supports Development Platform for Oncosoft's AI Medical Imaging Analysis Software 'OncoStudio 2.0'
Qt Group supported Oncosoft in enhancing the platform for its AI-based auto-contouring software, 'OncoStudio 2.0,' leading to real-time visualization of high-resolution 3D medical images. This collaboration resulted in a 2x improvement in UI implementation speed and a 20% reduction in UI-related bugs.
2025-04
PMC
Automated Organ Segmentation for Radiation Therapy: A Comparative Analysis of AI-Based Tools Versus Manual Contouring in Korean Cancer Patients
This study evaluated OncoStudio, an AI-based auto-segmentation tool, against manual contouring and another AI tool in Korean cancer patients. The results showed OncoStudio's superior accuracy in delineating organs at risk across various body regions, with clinicians favoring its clinical suitability in 70% of cases.
2024-10
Tracxn
OncoSoft - 2026 Funding Rounds & List of Investors - Tracxn
OncoSoft has raised a total of $11.2 million over two funding rounds, including a Series B round of $8.25 million from investors like BNH INVESTMENT and HB Investment, and a Series A round of $2.68 million.
2026-04

Frequently Asked Questions

OncoSoft's OncoStudio utilizes AI for precise auto-contouring of organs at risk and tumor sites, significantly reducing manual contouring time from hours to minutes. This improves efficiency and accuracy in radiation therapy planning by generating consistent, expert-level contours and supporting various body regions.
OncoFlow is an integrated workflow management platform designed to streamline the entire radiation therapy process. It automates data flow between systems, integrates with TPS, R&V, and OIS, and includes comprehensive quality management tools to reduce errors and improve coordination.
OncoSoft is actively developing OncoPlan for optimizing particle therapy treatments with AI-guided dosimetry and OncoRPT for radiopharmaceutical therapy workflow management, aiming for personalized dosimetry and integrated patient monitoring. These solutions are currently in progress to further enhance treatment precision.
OncoSoft's OncoStudio has obtained U.S. FDA 510(k) clearance, and the company is pursuing regulatory approvals in other key global markets. They adhere to international standards like DICOM and HL7 FHIR and implement administrative and technical measures, including access control and encryption, to ensure data security and privacy.
While specific pricing models are not detailed, OncoSoft focuses on cost-effectiveness by streamlining workflows and automating administrative tasks. They offer 24/7 support for technical, physics, and clinical issues, alongside a feedback system to promptly address customer needs and continuously improve products.
OncoSoft has established partnerships with leading institutions like the Mayo Clinic and Yonsei Cancer Hospital for research and adoption of its AI solutions. Founded in 2019, the company recently secured $8.03 million in Series B funding and is preparing for an IPO, demonstrating strong financial stability and a clear growth trajectory.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.